Trial Profile
Questionnaire survey on malnutrition when encapsulating Enzarutamide, in collaborat on with a pharmacy dispensing pharmacy at Hakodate Municipal Hospital -Part2-
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2021
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 27 Dec 2021 Status changed from recruiting to completed.
- 04 Feb 2021 Planned End Date changed from 31 Dec 2019 to 31 Dec 2022.
- 24 Dec 2019 Planned End Date changed from 30 Sep 2019 to 31 Dec 2019.